title: Current update on medullary thyroid carcinoma.
abstract: OBJECTIVE
  This article will review the multimodality imaging spectrum of medullary thyroid carcinoma (MTC) with an emphasis on anatomic and functional imaging. Recent advances in the molecular cytogenetics of this tumor and the impact on diagnosis, prognosis, and development of novel targeted therapy will be discussed.
  
  
  CONCLUSIONS
  MTC is a neuroendocrine tumor with unique clinicopathologic and radiologic features compared with other thyroid malignancies. Imaging plays an important role in the optimal management of this malignancy.
authors.affiliation: 1 Department of Diagnostic Imaging, Unit 1473, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030-4009.
authors.forename: Dhakshinamoorthy
authors.initials: D
authors.lastname: Ganeshan
authors.forename: Erik
authors.initials: E
authors.lastname: Paulson
authors.forename: Cihan
authors.initials: C
authors.lastname: Duran
authors.forename: Maria E
authors.initials: ME
authors.lastname: Cabanillas
authors.forename: Naifa L
authors.initials: NL
authors.lastname: Busaidy
authors.forename: Chusilp
authors.initials: C
authors.lastname: Charnsangavej
mesh_terms: D014408:Biomarkers, Tumor / Q000032:analysis; D018276:Carcinoma, Medullary / Q000175:diagnosis* / Q000628:therapy; D003937:Diagnosis, Differential; D003952:Diagnostic Imaging; D006801:Humans; D011379:Prognosis; D013964:Thyroid Neoplasms / Q000175:diagnosis* / Q000628:therapy
chemical_list: D014408:Biomarkers, Tumor